Currently, the share price for Emcure Pharmaceuticals Ltd. is delayed. Login to view live prices.
Emcure Pharmaceuticals Ltd.
₹1,405.25
NSE
-- ( -- %) 1D
- Prev. Close1,405.25
- Upper Circuit1,533.70
- Lower Circuit1,254.90
Analyst Sentiment For Emcure Pharmaceuticals Ltd.
There seem to be no recommendations on this stock from the analyst universe covered
Returns
Emcure Pharmaceuticals Ltd.'s Info & Management
Emcure Pharmaceuticals is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally.
- Chief Executive Officer(Subsidiary Company)Sanjay Singh
- Managing Director(Subsidiary Company)Prakash Kumar Guha
- President(Corporate Development)Vikas Madan Thapar
- President(Emerging Markets)Sanjay Rajanikant Mehta
- President(Technical Operations)Deepak Gondaliya
- President(API.)Kuber Mahadeo Jagdale
FAQs on Emcure Pharmaceuticals Ltd.
What is the share price of Emcure Pharmaceuticals Ltd.?
Emcure Pharmaceuticals Ltd. share price is ₹1,390.00 as of September 6, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Emcure Pharmaceuticals Ltd.?
The 52-week high and low of Emcure Pharmaceuticals Ltd. is ₹1,452.90 and ₹1,226.95 respectively as of September 6, 2024, 03:29 PM.
52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PB ratio of Emcure Pharmaceuticals Ltd.?
The trailing twelve month (TTM) PB ratio of Emcure Pharmaceuticals Ltd. is 8.56 as of September 8, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Emcure Pharmaceuticals Ltd.?
The Upper Circuit of Emcure Pharmaceuticals Ltd. is ₹1,534.
The Lower Circuit of Emcure Pharmaceuticals Ltd. is ₹1,255.
What is the ROE of Emcure Pharmaceuticals Ltd.?
Emcure Pharmaceuticals Ltd. reported an ROE of 18.27% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Emcure Pharmaceuticals Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Emcure Pharmaceuticals Ltd., Promoter held 78.1%, the FII held 1.8%, DII held 3.4% and the public held 16.8% of the total shares.
How to buy Emcure Pharmaceuticals Ltd. Share?
You can easily buy shares of Emcure Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
What is the fair value of Emcure Pharmaceuticals Ltd.?
The fair value of Emcure Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer